Regenerative Medicine

2017 FDA Announcement – Stem Cell Procedures

By February 26, 2018 September 16th, 2019 No Comments


The FDA announced new regulations for tissue harvesting and stem cell procedures in late 2017. Our CELLAXYS physicians have been involved and actively following these new regulations from their inception. All of our procedures are fully compliant with the new, more strict regulations. CELLAXYS procedures have always been safe, reliable, effective, and reproducible. We are committed to safety and efficacy in everything we do. As technology and regulations continue to evolve, we will provide regular updates.
Reference

Dr. Matthew H.C. Otten
Sports Medicine, Board Certified
Advanced Orthopedics & Sports Medicine
Las Vegas, Nevada

Dr. Matthew HC Otten

Dr. Matthew HC Otten

Director of Orthopedic & Orthobiologics
Fellowship-trained & Board Certified in Sports medicine
Director Angiography at Harvard Clinical Research Institute
Michigan Stage University Alumni